Yahoo! Finance Search - Finance Home - Yahoo! - Help

Tuesday, March 28 2017 8:12am ET - U.S. Markets open in 1 hour and 18 minutes.
Industry Center - Biotechnology
Industry Center > Biotechnology > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Biotechnology News
Latest News
Tuesday, Mar 28, 2017
·Lifshitz & Miller LLP Files Class Action Lawsuit against OvaScience, Inc.
PR Newswire - 1 hour, 30 minutes ago
·DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Alcobra, Ltd. To Contact The Firm
Business Wire - 2 hours, 57 minutes ago
·Tesaro wins FDA approval for potential blockbuster cancer drug
at - Mon 8:42 pm ET
·IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Stemline Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
Business Wire - Mon 6:26 pm ET
·SHAREHOLDER ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against Regulus Therapeutics Inc. and Encourages Investors With Losses to Contact the Firm
Business Wire - Mon 6:05 pm ET
·Amgen's Humira Biosimilar Approved in Europe
- Mon 5:49 pm ET
·Shareholder Alert: Monteverde & Associates PC Announces An Investigation Of ADMA Biologics, Inc. - ADMA
PR Newswire - Mon 5:39 pm ET
·[$$] Alexion Names New CEO Following Internal Sales-Practice Probe
at The Wall Street Journal Online - Mon 5:29 pm ET
·Osiris Therapeutics, Inc. Completes Restatement of 2014 Financial Statements
GlobeNewswire - Mon 5:15 pm ET
Monday, Mar 27, 2017
·Adaptimmune to Participate in Upcoming Jefferies Immuno-Oncology Summit
GlobeNewswire - Mon 4:34 pm ET
·Tesaro stock rises 6% on news that its ovarian cancer drug was approved by the FDA
at MarketWatch - Mon 4:24 pm ET
·Threshold Pharmaceuticals posts 4Q loss
AP - Mon 4:18 pm ET
·AmpliPhi Biosciences Reports 2016 Fourth-Quarter and Full-Year Results and Provides Corporate Highlights
Business Wire - Mon 4:11 pm ET
·Tesaro Secures Early and Broad Approval for PARP Inhibitor in Ovarian Cancer
at - Mon 4:07 pm ET
·Dicerna Pharmaceuticals to Present at the BioCentury 24th Annual Future Leaders in the Biotech Industry Conference
Business Wire - Mon 4:05 pm ET
·Exelixis to Present at the Needham & Company Healthcare Conference on April 4
Business Wire - Mon 4:05 pm ET
·Ocera to Present at the 16th Annual Needham Healthcare Conference
GlobeNewswire - Mon 4:05 pm ET
·TRACON Pharmaceuticals Announces TRC694 Data Presentation at Upcoming AACR Annual Meeting
GlobeNewswire - Mon 4:05 pm ET
·Calithera Biosciences, Inc. Announces Closing of Public Offering and Exercise in Full of Option to Purchase Additional Shares
GlobeNewswire - Mon 4:04 pm ET
·Blueprint Medicines to Present on BLU-285 and BLU-554 at Upcoming Scientific Conferences
PR Newswire - Mon 4:01 pm ET
More Latest News...

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Biotechnology Headlines
More Finance RSS Feeds

Copyright © 2017 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2017 Morningstar, Inc. All Rights Reserved. Company information © 2017 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2017, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?